002241:SZSEGoertek Inc. Analysis
Data as of 2026-03-17 - not real-time
CN¥25.24
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Goertek is trading at CNY 25.24, comfortably below its 20‑day (CNY 25.88), 50‑day (CNY 27.48) and 200‑day (CNY 27.77) moving averages, indicating a short‑term bearish bias. The price sits just above the calculated support of CNY 24.22 and well under the near‑term resistance of CNY 27.20, with a neutral RSI of 40 and a MACD histogram that has turned positive, suggesting a tentative bullish signal amid decreasing volume. Volatility remains high at roughly 30% over the past 30 days, yet the beta of 0.52 points to lower systematic risk compared with the broader market. Fundamentally, the company posted 4.4% revenue growth and maintains modest margins (gross 12%, operating 5%). Its trailing PE of 30 is below the industry average of 34, and the forward PE of 23.5 signals improving earnings expectations. The dividend yield of 1.59% with a 30% payout ratio appears sustainable, while the DCF‑derived fair value of CNY 7.84 suggests the market may be pricing in a premium, leaving an upside potential of about 36% to consensus analyst targets. Overall, Goertek blends a value‑oriented valuation with modest growth prospects and a stable dividend, but technical pressure and high short‑term volatility temper the near‑term outlook.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below all major moving averages
- Decreasing volume and high short‑term volatility
- Support level near CNY 24.22 offering limited downside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Valuation gap (PE below industry, upside ~36%)
- Sustainable dividend yield of 1.59%
- Forward earnings growth implied by lower forward PE
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Exposure to growing smart‑wearable and VR markets
- Moderate leverage with debt‑to‑equity around 59%
- Stable cash generation and dividend sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth4.40%
Profit Margin2.92%
P/E Ratio30.0
ROE8.17%
ROA2.05%
Debt/Equity59.11
P/B Ratio2.5
Op. Cash FlowCN¥5.0B
Free Cash FlowCN¥1.7B
Industry P/E34.2
Technical Analysis
TrendBearish
RSI40.1
SupportCN¥24.22
ResistanceCN¥27.20
MA 20CN¥25.88
MA 50CN¥27.48
MA 200CN¥27.77
MACDBullish
VolumeDecreasing
Fear & Greed Index79.45
Valuation
Fair ValueCN¥7.84
Target PriceCN¥34.30
Upside/Downside35.90%
GradeOvervalued
TypeValue
Dividend Yield1.59%
Risk Assessment
Beta0.52
Volatility29.72%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.